{
  "docId": "019de516-9989-7672-a652-fe437099830c",
  "docSlug": "dc4b6dd31d750eecf6a392f7e2ae4db2",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 22 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 22,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "other",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 10,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-9989-7672-a652-fe437099830c/19",
  "deckHref": "/decks/019de516-9989-7672-a652-fe437099830c",
  "deckJsonHref": "/decks/019de516-9989-7672-a652-fe437099830c.json",
  "deckAnchorHref": "/decks/019de516-9989-7672-a652-fe437099830c#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.08,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Revenues ($M)\nQ2 2022: $9.6M ($7.7 Cell Therapy, $1.9 Drug Discovery)\nQ2 2023: $9.0M ($6.6 Cell Therapy, $1.7 Drug Discovery, $0.8 Program-related)",
      "attrs": {
        "series": [
          "Cell Therapy",
          "Drug Discovery",
          "Program-related"
        ],
        "x_axis_label": "Quarter",
        "y_axis_label": "Revenues ($M)"
      },
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f86a810-856f-45a9-9817-2ed1a9ebb1dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.37,
        "x": 0.55,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Operating Expenses ($M)\nQ2 2022: $17.2M\nQ2 2023: $20.7M",
      "attrs": {
        "x_axis_label": "Quarter",
        "y_axis_label": "Operating Expenses ($M)"
      },
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "286078df-b156-429b-99fd-eb7c4800ebbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.8,
        "y": 0.05
      },
      "kind": "image",
      "text": "MaxCyte logo",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "211d979f-bf5d-4dfa-9ea8-df6082085131",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.15,
        "x": 0.21,
        "y": 0.7
      },
      "kind": "metric",
      "text": "Gross Margins ~85%",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a39ce94-a691-4e0b-a363-6bf1d1e95c45",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.01,
        "x": 0.49,
        "y": 0.96
      },
      "kind": "other",
      "text": "19",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9512405-7619-421c-a371-e90063166fc3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.39,
        "x": 0.57,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "Balance Sheet\nTotal cash, cash equivalents and short-term investments were $216 million as of June 30, 2023",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "539f7bfb-6b77-49ea-bd10-ece27a05f787",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.16,
        "x": 0.82,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48287b3c-1cb6-4c21-ad22-701fef171070",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.42,
        "x": 0.042,
        "y": 0.06
      },
      "kind": "title",
      "text": "Q2 2023 Key Financial Highlights",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b897cabf-cf5f-4753-bdb7-bc6f16fb3247",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 21,
      "from": 18,
      "beatId": "885c7f79-110c-42fb-aaa1-ac8421a74f57",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "Financials are presented on pages 18-21",
      "position": 5,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}